Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
The seed round was led by Mercia through the Northern Powerhouse Investment Fund to support platform enhancements and team growth.
"There has been growing recognition amongst businesses of the importance of employee health and wellbeing and the pandemic has brought this into even sharper focus. As we move into 2021, monitoring, measuring and having the ability to respond to the needs of employees will be critical as we transition back to work."
Seven members of Henley Business Angels contributed £145k as part of the overall investment.
"I’m delighted to be taking investment from such a dynamic and engaged network – we are looking forward to harnessing the specific expertise of our investors as well as using the funding wisely to generate significant value over the year ahead."
The digital healthcare provider secured £55.7m via an initial public offering to fund its expansion plans.
"today marks an important milestone in Doctor Care Anywhere’s journey to become a global leader in digital health, through joining up the patient journey and making it work better for patients. The capital we’ve raised with this IPO will allow us to better serve our current patients with a more extensive range of services, and accelerate our growth plans to make digital health another valuable UK export that patients around the world can benefit from."
The funding was secured from Wealth Club and the Development Bank of Wales to support product development and global expansion.
"Our purpose has always been to help people be better with data. This funding is a fantastic recognition of our hard work and shows a strong belief and confidence in our forward mission as a business."
Seedcamp led the financing round to help fund the digital health startup's public rollout.
"While working as a doctor, I saw firsthand the devastating complications of type 2 diabetes – from strokes to heart attacks to blindness. For the majority of patients, pills are not solving the problem. We now have strong clinical evidence that remission can be the goal for most patients. Sadly, with the NHS at a breaking point, it is not in a place to deliver intensive remission programs to the 4.2 million type 2 diabetics in the UK."
